FGFR4 and glioblastoma: In order to evaluate the impact of FGFR4 on the malignant phenotype of GBM, we performed DESeq2 analyses of the FGFR4high versus FGFR4low subgroups of the RNA sequencing TCGA-GBM dataset (compare Fig. 1C).